C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 2,280.00
-15.00 (-0.65%)
At close: Oct 2, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 26.2 billion as of October 2, 2026. Its market cap has decreased by -53.52% in one year.
Market Cap
26.20B
Enterprise Value
23.44B
Revenue
63.55B
Ranking
n/a
PE Ratio
15.85
Stock Price
2,280.00
ChartMarket Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 19.05B to 26.20B, an increase of 37.55%. That is a compound annual growth rate of 6.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 26.20B | -49.34% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 468.92% |
| Dec 9, 2021 | 19.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 384.44B |
| DreamCIS | 90.41B |
| HLB bioStep | 49.46B |
| P&K Skin Research Center | 47.65B |
| Kolmar BioTech | 39.04B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 25.22B |
| Curachem | 12.65B |